QuantumScape
QS
$7.41
+1.37%
QuantumScape Corporation is a development-stage company focused on creating next-generation solid-state lithium-metal batteries for electric vehicles and other applications, operating within the Auto - Parts industry. The company is a pure-play technology disruptor aiming to commercialize a solid-state battery design that promises significantly higher energy density, faster charging, and improved safety compared to conventional lithium-ion batteries. The current investor narrative is intensely focused on the company's progress toward commercialization against a backdrop of persistent cash burn, with recent news highlighting the speculative nature of the investment given the multi-year path to meaningful revenue and ongoing technical validation milestones.…
QS
QuantumScape
$7.41
Related headlines
Investment Opinion: Should I buy QS Today?
Rating: Hold. The core thesis is that QuantumScape is a high-risk, binary speculation on unproven technology; while the potential reward is substantial, the current combination of zero revenue, high cash burn, negative momentum, and lack of analyst conviction does not justify a Buy rating for most investors. Supporting evidence includes the company's strong liquidity (current ratio 15.95) which provides a multi-quarter runway, a slight improvement in quarterly net losses (from -$114.7M to -$100.1M), and a market cap that still assigns significant value to its IP (P/B 5.13). However, these are outweighed by the -53.78% six-month price decline, the unsustainable -$278.8M TTM free cash flow, and the extreme uncertainty reflected in analyst revenue estimates ranging from $152M to $936M. The thesis would upgrade to a speculative Buy only on concrete, verifiable progress toward commercialization (e.g., a firm production timeline from Volkswagen, a new major partnership, or a drastic reduction in cash burn). It would downgrade to Sell on a breach of the $3.65 support level, a significant dilution event, or a major partnership setback. Relative to its own potential and peer pre-revenue tech stocks, QS is arguably fairly valued given the immense risk, but it is unequivocally overvalued on any traditional fundamental metric.
Sign up to view all
QS 12-Month Price Forecast
The 12-month outlook for QS is a holding pattern fraught with volatility. The base case (50% probability) is a continued range-bound trade between $6 and $10, reflecting the stalemate between its solid balance sheet and lack of progress. The bear case (30%) carries significant weight due to the fundamental pre-revenue risks and negative momentum. The bull case (20%), while offering substantial upside, requires a low-probability series of positive technical and business developments. The stance would upgrade to bullish on confirmation of a viable production timeline, and downgrade to bearish on a breakdown below $3.65 support.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QuantumScape's 12-month outlook, with a consensus price target around $9.63 and implied upside of +30.0% versus the current price.
Average Target
$9.63
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$6 - $10
Analyst target range
Analyst coverage is limited, with only 6 analysts providing estimates, and the provided data does not include a consensus price target or recommendation, indicating insufficient consensus for a clear directional signal. The wide range in forward estimates, with revenue expectations spanning from $151.8 million to $935.9 million, underscores the extreme uncertainty and lack of visibility into the company's commercial timeline and potential market share. Recent institutional rating actions show a cautious to negative bias, with firms like Evercore ISI downgrading from Outperform to In Line and HSBC oscillating between Hold and Reduce, reflecting growing skepticism about the near-term path to commercialization. The absence of a clear price target consensus and the downgrade activity suggest that while a small cohort of analysts tracks the story, institutional conviction is weak, which aligns with the stock's high volatility and speculative profile, leaving investors to base decisions almost entirely on technological progress reports rather than analyst guidance.
Bulls vs Bears: QS Investment Factors
The evidence currently tilts decisively bearish, grounded in the harsh reality of zero revenue, persistent cash burn, and severe negative price momentum. The bull case rests entirely on future technological success and a strong balance sheet, while the bear case is supported by present fundamentals and market sentiment. The single most important tension in the investment debate is the race against time: Can QuantumScape achieve meaningful commercial milestones and revenue before its substantial cash reserves are depleted by its -$100 million quarterly burn rate? The resolution of this tension will determine whether the stock is a deep-value turnaround or a value trap.
Bullish
- Strong Balance Sheet & Liquidity: The company has a robust current ratio of 15.95 and a low debt-to-equity ratio of 0.06, with $244.2 million in cash as of Q4 2025. This provides a significant financial runway to fund its multi-year development path without immediate solvency concerns, a critical advantage for a pre-revenue company.
- Improving Operational Discipline: Quarterly net losses have shown a slight improving trend, decreasing from -$114.7 million in Q2 2025 to -$100.1 million in Q4 2025. This suggests management is exercising some cost control amidst heavy R&D spending, which is crucial for extending the cash runway.
- Deeply Oversold Technical Condition: The stock is trading at $7.10, near the bottom of its 52-week range ($3.65 to $19.07) and has declined 53.78% over the past six months. This extreme pessimism, coupled with a recent 3.65% monthly gain, could indicate a potential technical bounce if sentiment shifts on positive news.
- High-Growth Potential Market: Analyst forward revenue estimates for the next year show a wide but ambitious range from $151.8 million to $935.9 million, averaging $495 million. This reflects the massive total addressable market for solid-state EV batteries if QuantumScape's technology is successfully commercialized.
Bearish
- Zero Revenue & Persistent Cash Burn: The company reported $0 in revenue for Q4 2025 and has a trailing twelve-month free cash flow of -$278.8 million. With no commercial product, the entire investment thesis is a binary bet on future success, with the clock ticking on its cash reserves.
- Severe Underperformance & Negative Momentum: The stock has underperformed the S&P 500 by -60.67% over the past six months and is down 32.70% over the last three months. This sustained downtrend reflects deep skepticism from the market regarding the timeline and probability of commercialization.
- Extreme Volatility & Speculative Profile: With a beta of 2.56, QS is over 150% more volatile than the market, prone to violent swings on sentiment. This high volatility, combined with a short ratio of 9.24, indicates a heavily contested and speculative stock unsuitable for risk-averse investors.
- Analyst Skepticism & Lack of Conviction: Recent institutional actions include downgrades (e.g., Evercore ISI to In Line) and only 6 analysts providing estimates, with no clear consensus price target. This reflects a lack of conviction and high uncertainty about the company's near-term prospects.
QS Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 53.78% over the past six months and 32.70% over the last three months, significantly underperforming the broader market. With a current price of $7.10, the stock is trading at approximately 37% of its 52-week range ($3.65 to $19.07), positioning it much closer to its annual lows, which suggests a deep value opportunity for believers in the technology but also reflects severe negative momentum and fundamental concerns. Recent momentum shows a slight divergence, with a 3.65% gain over the past month, which contrasts sharply with the longer-term downtrend; however, this minor uptick is likely a technical bounce within a bear market, especially given the stock's extreme beta of 2.56, indicating it is over 150% more volatile than the market and prone to sharp swings on sentiment shifts. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $19.07 and critical support at the 52-week low of $3.65. A sustained break below the $3.65 support would signal a complete loss of confidence and potentially lead to a further precipitous decline, while any meaningful recovery would need to overcome a series of lower highs established during the downtrend. The stock's high beta of 2.556 underscores its speculative, high-risk nature, meaning position sizing must account for the potential for violent moves in either direction relative to the overall market.
Beta
2.56
2.56x market volatility
Max Drawdown
-67.7%
Largest decline past year
52-Week Range
$4-$19
Price range past year
Annual Return
+86.2%
Cumulative gain past year
| Period | QS Return | S&P 500 |
|---|---|---|
| 1m | +8.8% | +8.5% |
| 3m | -28.5% | +2.8% |
| 6m | -55.9% | +4.6% |
| 1y | +86.2% | +32.3% |
| ytd | -33.0% | +3.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QS Fundamental Analysis
The company has no commercial revenue, reporting $0 in revenue for the most recent quarter ending December 31, 2025, and this has been consistent for multiple quarters, placing the entire investment thesis on future commercialization success rather than current financial performance. The net loss for Q4 2025 was $100.1 million, with a gross profit of negative $15.4 million, indicating costs associated with development and prototyping far exceed any incidental income; however, the quarterly net loss has shown a slight improving trend from -$114.7 million in Q2 2025 to -$100.1 million in Q4 2025, suggesting some operational discipline is being exercised amidst heavy spending. Profitability metrics are deeply negative, with a trailing twelve-month free cash flow of -$278.8 million and an ROE of -37.22%, reflecting the capital-intensive, pre-revenue nature of the business. The balance sheet shows a strong current ratio of 15.95 and a low debt-to-equity ratio of 0.061, indicating substantial liquidity with $244.2 million in cash at the end of Q4 2025 and minimal leverage, which provides a runway to fund operations but does not mitigate the core risk of the technology failing to reach commercial scale. The company's financial health is currently defined by its cash burn rate, with the key question being whether its cash reserves and potential future financing can sustain operations long enough to achieve revenue-generating production.
Quarterly Revenue
$0.0B
2025-12
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$-278750000.0B
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QS Overvalued?
Given the company's negative net income of -$100.1 million and negative EBITDA of -$83.9 million, traditional earnings-based multiples are not applicable; therefore, the analysis leads with the Price-to-Sales (PS) ratio, which is 0 due to the absence of revenue, highlighting the speculative, future-dependent nature of the valuation. Compared to industry averages, a PS ratio of 0 is not directly comparable, but the market capitalization of approximately $6.0 billion assigns significant value purely to the company's intellectual property and potential, a premium that must be justified by future commercial success in a highly competitive battery sector. Historically, the stock's own valuation context is provided by its Price-to-Book (PB) ratio, which at 5.13 is above its recent historical range observed in the data (e.g., 2.06 in Q1 2025 and 5.74 in Q3 2025), suggesting the market is still attributing a substantial premium to its equity base despite the severe price decline, possibly reflecting the value of its patented technology and partnership with Volkswagen. The current valuation sits in a nebulous zone where traditional metrics fail, leaving the stock price entirely driven by binary outcomes related to technical milestones and partnership updates rather than financial fundamentals.
PE
-13.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -55x~167x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-16.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are paramount. QuantumScape burns cash at a rate of approximately -$100 million per quarter, with a TTM free cash flow of -$278.8 million. While the current cash position of $244.2 million and minimal debt (D/E of 0.06) provide a runway, the complete absence of revenue ($0) means the company is entirely dependent on future financing or partnership payments to survive until commercialization. Profitability metrics are deeply negative (ROE of -37.2%), and the path to positive gross margins is multi-year and uncertain. Market & Competitive Risks are severe. The stock trades at a significant premium to its tangible book value (P/B of 5.13), a valuation entirely predicated on future success. With a beta of 2.56, it is hypersensitive to market sentiment and risk-off environments, which could compress its speculative multiple further. The company faces intense competition from established battery giants and other solid-state startups, any of which could achieve commercialization first, rendering QS's technology obsolete. Recent analyst downgrades highlight growing skepticism about its timeline. Worst-Case Scenario involves a critical technical failure, a major delay announced by its partner Volkswagen, or a failure to secure additional funding. This could trigger a complete loss of investor confidence, leading to a re-rate towards the value of its net cash. The stock could realistically fall to its 52-week low of $3.65, representing a downside of approximately -49% from the current price of $7.10. Given the stock's history of a -67.68% max drawdown, a decline of this magnitude is within the realm of historical precedent for this highly volatile name.
FAQ
The key risks are, in order of severity: 1) Technological/Commercialization Risk: The core technology may fail to scale profitably, rendering the company worthless. 2) Financial Risk: The company burns ~$100M per quarter; without revenue, it risks dilution or bankruptcy before achieving its goals. 3) Competitive Risk: Larger, better-funded competitors may beat QS to market with solid-state batteries. 4) Market Risk: The stock's extreme volatility (beta 2.56) and high short interest (short ratio 9.24) make it prone to sharp declines on negative sentiment or broad market sell-offs.
The 12-month forecast is highly uncertain, with three primary scenarios. The base case (50% probability) sees the stock trading between $6 and $10, as it continues its development without major news. The bear case (30% probability) could see a drop to $3.65-$5 on a technical or partnership setback. The bull case (20% probability) could drive the stock to $15-$19 on a major positive catalyst. The base case is most likely, assuming no dramatic changes to the current development trajectory and sentiment. The wide forecast range underscores its speculative nature.
QS is impossible to value using traditional metrics as it has no revenue (PS=0) and negative earnings (PE=-13.8). Its $6.0 billion market cap and Price-to-Book ratio of 5.13 indicate the market is assigning a large premium to its intellectual property and partnership potential. Compared to profitable companies, it is astronomically overvalued. Within the context of pre-revenue, venture-stage tech stocks, it could be seen as fairly valued given the scale of its potential market, but this remains a speculative assessment. The valuation implies the market expects successful commercialization within the next several years.
QS is not a good stock to buy for the vast majority of investors. It is a highly speculative bet on unproven technology with zero current revenue and a -$278.8 million annual cash burn. The potential upside is large (analyst high revenue estimate ~$936M), but the probability of success is low and the downside to the 52-week low of $3.65 represents a -49% loss. It may only be suitable for a very small, risk-capital portion of a portfolio for investors who deeply understand the technology and can tolerate extreme volatility (beta 2.56).
QS is categorically unsuitable for short-term investment or trading for most, due to its extreme volatility (beta 2.56) and lack of earnings-based catalysts. It is a long-term, multi-year investment thesis by nature, as commercialization is likely 3-5 years away, if it happens at all. However, it is only suitable for long-term holding by investors who can commit to that timeframe and are prepared for the stock to potentially go to zero. A suggested minimum holding period, if one invests, is 3-5 years to see through key development milestones, but this carries immense risk.